Viral, Julieta .
HRN: 23-46-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CEFUROXIME 1.5GM (VIAL)
08/02/2023
08/08/2023
IV
1.5g
Q8h
Soft Tissue Injury
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes